Cafepharma Today

June 27 2025 - ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
VC legal dispute threatens biotech startups
Multiple sclerosis market expected to reach $25.9bn across the 7MM by 2034
Novo Nordisk Foundation gives $75m for R&D 'challenges'
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Daiichi Sankyo reports positive data for anticoagulant drug
Pharmaceutical Business Review
Thursday, September 4, 2008 - 8:20am
tags:
Akorn-Strides wins approval for two new drugs
Pharmaceutical Business Review
Thursday, September 4, 2008 - 8:18am
tags:
Merck KGaA, Ablynx sign up to $484 mln drug deal
Forbes
Thursday, September 4, 2008 - 8:17am
tags:
Top Statistician Says Vytorin Cancer Risk 'Not Ruled Out'
Forbes
Thursday, September 4, 2008 - 8:16am
tags:
Pfizer staking millions on Alzheimer's hunch
The Day, CT
Thursday, September 4, 2008 - 8:16am
tags:
Epix regains rights to MRA agent from Bayer
Marketwatch
Thursday, September 4, 2008 - 8:15am
tags:
A Win For Regeneron
Forbes
Thursday, September 4, 2008 - 8:12am
tags:
Flash: Vytorin Study Not A Conspiracy
Forbes
Thursday, September 4, 2008 - 8:11am
tags:
UCB Pharma to Rebrand as Specialty Company
PharmExec
Thursday, September 4, 2008 - 8:08am
tags:
Forest Labs, Almirall report on studies of COPD drug
Marketwatch
Wednesday, September 3, 2008 - 11:18am
tags:
Cyclacel Pharma in Early Cycle
Yahoo/Zacks.com
Wednesday, September 3, 2008 - 11:16am
tags:
Exelixis: A Platform Company for Oncology
Seeking Alpha
Wednesday, September 3, 2008 - 11:16am
tags:
Vertex Pharma downgraded to 'Perform' as analyst says stock will stay at recent levels
Yahoo/AP
Wednesday, September 3, 2008 - 11:14am
tags:
Were Vytorin Cancer Data Made Public Too Soon?
WSJ Online
Wednesday, September 3, 2008 - 9:03am
tags:
Pfizer paying up to $725 million for Alzheimer drug rights
Marketwatch
Wednesday, September 3, 2008 - 8:52am
tags:
Novartis: Tekturna better than diuretic for obese patients
Marketwatch
Wednesday, September 3, 2008 - 8:48am
tags:
Vytorin Study's Ethical Morass
Forbes
Wednesday, September 3, 2008 - 8:47am
tags:
Has Lilly's Effient Been FDA Approved?
Seeking Alpha
Wednesday, September 3, 2008 - 8:46am
tags:
Teva sells Ivax Diagnostics stake
Globes Online, Israel
Wednesday, September 3, 2008 - 8:43am
tags:
Zentiva CEO tells shareholders to reject Sanofi bid
Reuters
Wednesday, September 3, 2008 - 8:43am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.